Biotech

February 20, 2026

Reading time: 4 minutes and 35 seconds

FDA Grants Fast-Track Status to First Senolytics Drug Targeting Cellular Aging

FDA Grants Fast-Track Status to First Senolytics Drug Targeting Cellular Aging. FDA Grants Fast-Track Status to First Senolytics Drug Targeting Cellular Aging. FDA Grants Fast-Track Status to First Senolytics Drug Targeting Cellular Aging.

Latest

Longevity Research

Dr. David Sinclair on the Next Frontier: Reprogramming Cells to Reverse Biological Age

Reading time: 11 minutes and 40 seconds

Longevity Research

Dr. Aubrey de Grey: “We’re Closer Than People Think”

Reading time: 12 minutes and 30 seconds

Nutrition

Time-Restricted Eating: What the Latest Research Actually Shows

Reading time: 5 minutes and 20 seconds

Curated, Peer-Reviewed

Telomere Extension Therapy Shows Promise in Phase II Human Trials

Reading time: 5 seconds

Explore Other Topics

Rapamycin Study Shows 15% Improvement in Age-Related Biomarkers

Rapamycin Study Shows 15% Improvement in Age-Related Biomarkers. Rapamycin Study Shows 15% Improvement in Age-Related Biomarkers. Rapamycin Study Shows 15% Improvement in Age-Related Biomarkers.

Reading time: 5 minutes and 50 seconds